Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan C Lo

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|February 23, 2017
The Perils of Trumping Science in Global Health - The Mexico City Policy and BeyondNathan C Lo, Michele Barry
Nature|July 12, 2023
A sustainable way to control the parasitic disease schistosomiasisNathan C Lo, Benjamin Arnold
The New England Journal of Medicine|August 21, 2023
Outbreaks in U.S. Migrant Detention Centers - A Vaccine-Preventable Cause of Health InequityNathan C Lo, Gregg S Gonsalves
The Lancet. Infectious Diseases|March 28, 2020
Scientific and ethical basis for social-distancing interventions against COVID-19Joseph A Lewnard, Nathan C Lo
BMJ (Clinical Research Ed.)|February 18, 2022
Predicting covid-19 outcomesAnand R Habib, Nathan C Lo
JAMA Pediatrics|July 25, 2017
Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United StatesNathan C Lo, Peter J Hotez
Health Affairs (Project Hope)|May 4, 2016
Abstinence Funding Was Not Associated With Reductions In HIV Risk Behavior In Sub-Saharan AfricaNathan C Lo, Anita Lowe, Eran Bendavid
The Lancet. Infectious Diseases|June 30, 2016
Improving helminth treatment access: costs and opportunitiesNathan C Lo, Jason R Andrews, Isaac I Bogoch
Plos Neglected Tropical Diseases|May 24, 2019
Antibacterial mass drug administration for child mortality reduction: Opportunities, concerns, and possible next stepsIsaac I Bogoch, Jürg Utzinger, Nathan C Lo, et al.
The Lancet. Global Health|February 6, 2016
Cost-effectiveness of community-wide treatment for helminthiasis--Authors' replyNathan C Lo, Isaac I Bogoch, Jürg Utzinger, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|February 23, 2017
The Perils of Trumping Science in Global Health - The Mexico City Policy and BeyondNathan C Lo, Michele Barry
Nature|July 12, 2023
A sustainable way to control the parasitic disease schistosomiasisNathan C Lo, Benjamin Arnold
The New England Journal of Medicine|August 21, 2023
Outbreaks in U.S. Migrant Detention Centers - A Vaccine-Preventable Cause of Health InequityNathan C Lo, Gregg S Gonsalves
The Lancet. Infectious Diseases|March 28, 2020
Scientific and ethical basis for social-distancing interventions against COVID-19Joseph A Lewnard, Nathan C Lo
BMJ (Clinical Research Ed.)|February 18, 2022
Predicting covid-19 outcomesAnand R Habib, Nathan C Lo
JAMA Pediatrics|July 25, 2017
Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United StatesNathan C Lo, Peter J Hotez
Health Affairs (Project Hope)|May 4, 2016
Abstinence Funding Was Not Associated With Reductions In HIV Risk Behavior In Sub-Saharan AfricaNathan C Lo, Anita Lowe, Eran Bendavid
The Lancet. Infectious Diseases|June 30, 2016
Improving helminth treatment access: costs and opportunitiesNathan C Lo, Jason R Andrews, Isaac I Bogoch
Plos Neglected Tropical Diseases|May 24, 2019
Antibacterial mass drug administration for child mortality reduction: Opportunities, concerns, and possible next stepsIsaac I Bogoch, Jürg Utzinger, Nathan C Lo, et al.
The Lancet. Global Health|February 6, 2016
Cost-effectiveness of community-wide treatment for helminthiasis--Authors' replyNathan C Lo, Isaac I Bogoch, Jürg Utzinger, et al.
Pageof 8